Mitochondrial NRG TM
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80049641
- Status
- Active licence
- Licence date
- 25 March 2014
- Revision date
- 12 January 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 5 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Thiamine Source : Chlorhydrate de thiamine | 12.5 mg | 50,000 µg |
| Acide (alpha-méthylguanido)acetique Source : Chélate de créatine magnésium | 137.5 mg | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 25 mg | Not calculated |
| Vitamine B6 Source : 5-phosphate de pyridoxal | 1.25 mg | 5,000 µg |
| trans-Resvératrol Source : Resvératrol | 25 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 500 mcg | 2,000 µg |
| Curcuma longa Source : Rhizome Potency : 95 % Curcuminoids | 25 mg | Not calculated |
| 3-Pyridinecarboxamide Source : Niacinamide | 1.25 mg | Not calculated |
Non-medicinal ingredients
Acide succinique, bêta Cyclodextrin, Hypromellose, Dioxyde de silicium, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps the body metabolize carbohydrates, fats, and proteins. Helps support fat metabolism. An antioxidant. Helps to maintain and/or support cardiovascular health. Source of CoEnzyme Q10, an antioxidant involved in supporting cellular energy production (mitochondrial synthesis of adenosine triphosphate (ATP)).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a healthcare practitioner prior to use if you have liver or kidney disease, or a seizure disorder. Consult a healthcare practitioner prior to use if you have been diagnosed with hypoglycemia or have diabetes. Consult a health care practitioner prior to use if you are taking blood pressure medication. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you have gallstones or a bile duct obstruction. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid. Consult a health care practitioner prior to use if you have a kidney disorder. May result in weight gain. Consult a healthcare practitioner prior to use if you are taking prescription medication. Consult a healthcare practitioner prior to use if you have a bleeding disorder.
Source
Official Health Canada record, licence 80049641
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging